Phase 3 Kidney Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with upper urinary tract cancer (in the kidney or ureter) confirmed by a biopsy, and you are scheduled for surgery to remove it with the goal of curing the disease
- You are between 18 and 90 years old
- Your doctor expects you to live for more than 1 year
- If you are a woman who could become pregnant, you must agree to use reliable birth control (such as hormonal methods, barrier methods, or abstinence) before, during, and for 90 days after the study — and you must tell your doctor right away if you become pregnant or think you might be pregnant during the study
- A woman is considered able to become pregnant for this study if she has not had her uterus or both ovaries removed, or has not gone through natural menopause for at least 12 months in a row
- You are able to understand what the study involves and are willing to sign a consent form agreeing to take part
Who may not be able to join:
- You have been diagnosed with bladder cancer at the same time or in the past, unless you have been cancer-free for at least three years
- You have the same type of cancer in both upper urinary tracts (both kidneys or ureters) at the same time — though a previous cancer on the other side is allowed if you have been cancer-free for more than three years
- Your surgical plan includes removing the entire bladder
- Your bladder is very small (holds less than 100 mL of fluid)
- You have had a serious allergic reaction to gemcitabine or similar medicines that may be used in this study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: (214) 648-0389
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
intravesical recurrence; intravesical recurrence
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.